MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce it successfully completed its first export shipment of medical cannabis concentrate into Australia to AusCann Group Holdings Ltd. Through its wholly owned subsidiary, MediPharm Labs Inc., the Company has become the first Canadian extraction-only company to publicly announce that it has received an export permit from Health Canada for the shipment of cannabis solid concentrate, under the new regulations, from Canada to Australia. Prior to the shipment, the Australian Government’s Office of Drug Control Section also issued an import permit.

OTC Markets Group Welcomes AusCann Group Holdings Ltd. to OTCQX

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced AusCann Group Holdings Ltd. (ASX: AC8; OTCQX: ACNNF), an Australian-based pharmaceutical company that aims to produce high quality, economical, and clinically validated cannabinoid medicines, has qualified to trade on the OTCQX® Best Market. AusCann upgraded to OTCQX from the Pink® market.